Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
Quick Stats
Jan 30, 202649.5
AI Score
HOLD0.55
Volume Ratio
Mar 17, 2026
Next Earnings
15
+ve Days (30d)
12
-ve Days (30d)
XBIO Stock Summary
Last updated Jan 30, 2026
XBIO is currently trading at $2.22, positioned below its 200-day moving average of $3.07, suggesting bearish momentum. The stock has a 52-week range of $1.9 to $13.93.
Technical Analysis: The 50-day moving average stands at $2.34, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.047, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.075, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates XBIO at 49.5/100 with a HOLD recommendation.
XBIO (Xenetic Biosciences, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.047 |
| CMF (20) | -0.075 |
| ROC (10) | -2.589 |
| ADX (14) | 23.68 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.028 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -93.504 |
| MFI (14) | 69.231 |
XBIO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
XBIO Price vs Max Options Open Interest
XBIO Max Change In Options Open Interest
XBIO Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XBIO Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XBIO Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XBIO Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Xenetic Biosciences, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
XBIO Moving Averages Analysis
XBIO (Xenetic Biosciences, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.49 |
| 20 | 2.35 |
| 30 | 2.27 |
| 50 | 2.34 |
| 100 | 3.02 |
| 200 | 3.07 |
XBIO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 5.7 million |
| Earnings/Share ($) | -2.04 |
| Net Proft Margin (%) | -1.104 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.04 |
| EPS Estimate Next Year ($) | -3.32 |
| WallStreet Target Price ($) | 40 |
| Most Recent Quarter |